USPTO serial 99897174
NEUROCORE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- DUBOIS, SUSAN L
- Law office
- TMO LAW OFFICE 111
What this means
Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months. Monitor TSDR for the examiner's first action. No filing is required until an office action or other requirement is issued.
Need help with NEUROCORE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Paramus, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Laura Franco
Laura Franco Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.44 Montgomery Street, 36th FloorSan Francisco, CA 94104United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for tracking, recording, monitoring, detecting, analyzing, predicting, displaying, and transmitting seizure-related data, biometric data, and patient health data; Downloadable computer software for tracking, recording, monitoring, analyzing, displaying, and transmitting seizure-related data, biometric data, and patient health data obtained from home monitoring devices, wearable devices, and medical sensors; Downloadable computer software for detecting, analyzing, predicting, and reporting seizure activity and seizure-related events; Downloadable computer software for generating automated alerts, notifications and reports relating to seizure activity, seizure risk, patient health conditions, and biometric events for patients, caregivers, healthcare providers, emergency responders, and family members; Downloadable computer software for remote patient monitoring and remote patient care management, namely, software for collecting, analyzing, displaying, and transmitting patient information, biometric data, and health data; Downloadable computer software for detecting, monitoring, recording, analyzing, displaying and transmitting electroencephalography (EEG) data and seizure-related data; Downloadable computer software for receiving, displaying, storing, analyzing, and transmitting real-time data from wearable electroencephalography (EEG) devices and other patient monitoring devices via wireless networks; Downloadable computer software for tracking and creating clinical reports on seizure history, symptoms, seizure triggers, medication adherence, treatment outcomes, and patient-reported health information; Downloadable computer software featuring artificial intelligence for analyzing patient health data, biometric data, electroencephalography (EEG) data, and seizure-related data for monitoring, detection, prediction, and clinical reporting and support purposes; Downloadable computer software for healthcare professionals for clinical decision support, namely, displaying patient seizure history, medication adherence information, symptom trends, trigger correlations, treatment data, risk assessments, and AI-generated clinical reports and summaries; Downloadable computer software for healthcare professionals for generating, displaying, and analyzing individualized health assessments and sudden unexpected death in epilepsy (SUDEP) risk information. | ACTIVE | — |
| 042 | Providing temporary use of online non-downloadable software for tracking, recording, monitoring, detecting, analyzing, predicting, displaying, and transmitting seizure-related data, biometric data, neurological data, and patient health data; Providing temporary use of online non-downloadable software for detecting, analyzing, predicting, and reporting seizure activity and seizure-related events; Providing temporary use of online non-downloadable software for generating automated alerts, notifications and reports relating to seizure activity, seizure risk, patient health conditions, and biometric events for patients, caregivers, healthcare providers, emergency responders, and family members; Software as a service (SaaS) services featuring software for tracking, recording, monitoring, analyzing, displaying, reporting and transmitting patient health data, seizure-related data, biometric data, and electroencephalography (EEG) data; Software as a service (SaaS) services featuring artificial intelligence software for monitoring, detecting, analyzing, predicting, and reporting seizure activity and related health conditions; Software as a service (SaaS) services featuring artificial intelligence software for analyzing and creating clinical reports based on patient health data, biometric data, and electroencephalography (EEG) data; Software as a service (SaaS) services featuring software for integrating patient health data with electronic health record (EHR) systems; Software as a service (SaaS) services featuring software for exchanging healthcare data with electronic health record systems using the Fast Healthcare Interoperability Resources (FHIR) standard; Software as a service (SaaS) services featuring software for clinical reporting and decision support for healthcare professionals managing seizure disorders and epilepsy patients; Software as a service (SaaS) services featuring software for tracking and creating clinical reports on seizure history, symptoms, seizure triggers, medication adherence, treatment outcomes, and patient-reported health information; Software as a service (SaaS) services featuring software for collecting, de-identifying, analyzing, and reporting patient health data, seizure-related data, and neurological data for pharmaceutical research and medical research purposes; Software as a service (SaaS) services featuring software for collecting, validating, analyzing, and reporting seizure event data and neurological health data for use in clinical research and clinical trials. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 29, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 26, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 9, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 9, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 9, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 22, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 22, 2026 | NWAP | NEW APPLICATION ENTERED | — |